Curtis L. Ruegg

[section title=”Three Columns With Header” id=”section4″ wide=true typography_md=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 28.57142858px;font-size: 20px;}” typography_sm=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 22.85714286px;font-size: 16px;}” typography_xs=”Text {line-height: 23.8px;}H1 {line-height: 51.42857144px;font-size: 36px;}” css=”padding-bottom:3em;padding-top:1em;” typography=”Text {line-height: 30.6px;font-weight: 400;font-size: 18px;color: #555555;text-align: center;}H4 {color: #002061;}H3 {line-height: 34.2857143px;font-size: 24px;font-weight: 600;text-transform: uppercase;}H1 {line-height: 85.71428574px;text-transform: uppercase;font-size: 60px;font-weight: normal;letter-spacing: 1px;}”]
[background_width][columns auto_height=1 vertical_align=”top” add_margins=true spacing_css_xs=”margin-top:-15px;margin-bottom:-15px;padding-top:15px;padding-bottom:15px;height:calc(130%);” spacing_css=”height:calc(110%);margin:-5px;padding:5px;”]
[column width_xs=”12″ css_xs=”padding:10px;” css=”padding:1em;”]
[image_scaling css=”background-position:right center;background-repeat:no-repeat;background-size:cover;”]
[image image_style=”imagestyles-23″ image=”https://amphivena.com/wp-content/uploads/amphivena-therapeutics-ceo-curtis-l-ruegg-phd.jpg” css_xs=”width:75%;” css=”width:20%;”][/image][/image_scaling]

[text tag=”h4″ typography_xs=”Text {line-height: 34.2857143px;font-size: 24px;}” typography=”Text {line-height: 42.85714287px;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;font-size: 30px;color: #002061;}”]Curtis Ruegg, Ph.D.[/text]

[text tag=”h4″ typography_xs=”Text {line-height: 28.57142858px;font-size: 20px;}” typography=”Text {line-height: 28.57142858px;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;font-size: 20px;}”]CEO & President[/text]

[separator content_type=”none” text=”Caption” text_tag=”span” align=”center” content_align=”center” href=”#” image=”https://cstatic.themler.io/themler/483/images/defaultImage.jpg” css=”padding:20px 0px;” image_css=”display:inline-block;” content_css=”margin-left:30px;margin-right:30px;” content_typography=”Text {color: #777777;}” line_css=”width:25%;border-top:1px solid #dddddd;”][/separator]

[text tag=”p” css_xs=”width:100%;” css=”width:70%;display:inline-block;” typography=”Text {line-height: 35px;text-align: justify;}”]During
more than 25 years in the biopharmaceutical industry, Curtis has built and
managed several successful novel biologics development programs, from research
through clinical development and resulting in health authority approval and
commercialization.   Prior to joining Amphivena, Curtis was President
and CEO at Parvus Therapeutics developing a novel biologics platform targeting
regulatory T cells for the treatment of autoimmune disease. Prior to Parvus,
Curtis was Executive Vice President, Technical Operations at Revance where he
established and managed the biologics development program to support the
Company’s first IND spanning through Phase 3. Prior to Revance, Curtis led
development efforts supporting commercialization of several products including
Ventavis® (CoTherix), Esbriet® (Intermune) and Provenge® (Dendreon). Curtis earned his Ph.D. degree from
Johns Hopkins University School of Medicine for research on retroviral mediated
immunosuppression and performed research in immunology as a Cancer Research
Institute Fellow at Stanford University School of Medicine.[/text]
[/column]
[/columns][/background_width]
[/section]

[section title=”Three Columns With Header” id=”section4″ wide=true typography_md=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 28.57142858px;font-size: 20px;}” typography_sm=”H3LinkPassive {line-height: 22.85714286px;font-size: 16px;}” typography_xs=”Text {line-height: 23.8px;}H1 {line-height: 51.42857144px;font-size: 36px;}” css=”padding-bottom:0em;padding-top:1em;background-color:#ffffff;” typography=”Text {line-height: 27.2px;text-align: center;color: #002061;font-size: 16px;font-weight: 400;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;}TextLinkPassive {color: #002061;}TextLinkHovered {color: #0070c0;}H3 {line-height: 25.71428573px;font-size: 18px;font-weight: 600;text-transform: uppercase;color: #002061;}H3LinkPassive {line-height: 22.85714286px;font-size: 16px;}H1 {line-height: 42.85714287px;text-transform: uppercase;font-size: 30px;letter-spacing: 1px;font-style: normal;font-weight: 600;color: #002061;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;}”]
[columns auto_height=1 vertical_align=”top” add_margins=true spacing_css_xs=”margin-top:-15px;margin-bottom:-15px;padding-top:15px;padding-bottom:15px;height:calc(130%);” spacing_css=”height:calc(110%);margin:-5px;padding:5px;”]
[column width_xs=”12″]
[html ]

[/html]

[text tag=”h1″ typography=”Text {font-weight: normal;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;color: #0070c0;}”]Leadership[/text]

[separator content_type=”none” text=”Caption” text_tag=”span” align=”center” content_align=”center” href=”#” image=”https://cstatic.themler.io/themler/480/images/defaultImage.jpg” css=”padding:10px 0px;” image_css=”display:inline-block;” content_css=”margin-left:30px;margin-right:30px;” content_typography=”Text {color: #777777;}” line_css_xs=”width:10%;” line_css=”width:5%;border-top:2px solid #000000;”][/separator]
[/column]

[column width_sm=”3″ css=”padding:1em;”]
[image href=”https://amphivena.com/curtis-l-ruegg-bio/” target=”_self” alt=”Curtis L. Ruegg” image=”https://amphivena.com/wp-content/uploads/amphivena-therapeutics-ceo-curtis-l-ruegg-phd.jpg” css_sm=”width:150px;height:155px;” css=”height:195px;width:195px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 25.71428572px;font-size: 18px;}”]Curtis Ruegg, Ph.D.
[/text]

[text tag=”p” css=”margin-top:0px;margin-bottom:0px;”]CEO & President[/text]
[/column]

[column width_sm=”3″ css=”padding:1em;”]
[image href=”https://amphivena.com/victoria-smith-bio/” target=”_self” alt=”Victoria Smith” image=”https://amphivena.com/wp-content/uploads/2019/05/amphivena-victoria.png” css_sm=”width:145px;height:156px;” css=”width:180px;height:193px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 25.71428572px;font-size: 18px;}”]


Victoria Smith, Ph.D.
[/text]

[text tag=”p” css=”margin-top:0px;”]


Chief Scientific Officer [/text]
[/column]

[column width_sm=”3″ css=”position:relative;padding:1em;”]
[image href=”https://amphivena.com/patrick-chun-bio/” target=”_self” alt=”Patrick Chun” image=”https://amphivena.com/wp-content/uploads/2019/07/amphivena-patrick-web.jpg” css_sm=”width:150px;height:152px;” css=”height:193px;width:191px;”][/image]

[text tag=”h3″ css=”margin-bottom:1px;” typography=”Text {line-height: 25.71428572px;font-size: 18px;}”]


Patrick Chun, M.D.
[/text]

[text tag=”p” css=”margin-top:1px;margin-bottom:0px;”]


Vice President[/text]

[text tag=”p” css=”margin-top:-8px;”]Clinical Development [/text]
[/column]

[column width_sm=”3″ css=”position:relative;padding:1em;”]
[image href=”https://amphivena.com/amy-penticoff-bio/” target=”_self” alt=”Amy Penticoff” image=”https://amphivena.com/wp-content/uploads/2019/05/amphivena-amy.png” css_sm=”width:150px;height:154px;” css=”width:189px;height:194px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 25.71428572px;font-size: 18px;}”]


Amy penticoff, MBA
[/text]

[text tag=”p” css=”margin-top:0px;margin-bottom:0px;”]


Vice President[/text]

[text tag=”p” css=”margin-top:-8px;”]Technical Operations [/text]
[/column]
[/columns]
[/section]